NGFR and malignant glioma: Because p75NTR has also been implicated in the progression of melanoma, and specifically in those tumors that metastasize to the brain [33,46,77], therapies that target p75NTR, p75NTR downstream effectors, or their ligands may not only be beneficial for malignant glioma, but may target other metastatic diseases.